Clinical Study to Evaluate the Efficacy of Anakinra in Patients With Rheumatoid Arthritis and Diabetes

NCT02236481 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

41

Enrollment

OTHER

Sponsor class

Stopped Decision of the Sponsor for Early Benefits

Conditions

Diabetes Mellitus, Type 2
Arthritis, Rheumatoid

Interventions

DRUG: Anakinra
DRUG: TNF alpha inhibitors

Sponsor

Prof. Roberto Giacomelli